Dexlansoprazole
Back to searchMolecule Structure
Scientific Name
Dexlansoprazole
Description of the Drug
Dexlansoprazole is a proton pump inhibitor used to help gastrointestinal ulcers heal, to treat symptoms of gastroesophageal reflux disease (GERD), to eradicate Helicobacter pylori, and to treat hypersecretory conditions such as Zollinger-Ellison Syndrome.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB05351
http://www.drugbank.ca/drugs/DB05351
Brand Name(s)
Dexilant, Dexilant solutab, Kapidex
Company Owner(s)
Par Pharmaceutical Inc, Takeda Pharmaceuticals Usa Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Potassium-transporting ATPase | PROTEIN COMPLEX | INHIBITOR | CHEMBL2095173 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL44975 | |
PharmGKB | PA166110257 | |
DrugBank | DB05351 | |
PubChem: Thomson Pharma | 14901842 | 15375021 |
PubChem | 9578005 | |
BindingDB | 50247930 | |
DrugCentral | 4162 | |
ChemicalBook | CB71269821 | |
Guide to Pharmacology | 5487 | |
rxnorm | DEXLANSOPRAZOLE | DEXILANT |
ChEBI | 135931 | |
ZINC | ZINC000003830986 |